학술논문
Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8)
Document Type
Article
Author
Source
In Gynecologic Oncology March 2016 140(3):450-456
Subject
Language
ISSN
0090-8258